Elle Communications is Agency of Record for FDA-Cleared Neurostimulation Device

Core Insights - NET Recovery has announced national treatments utilizing its FDA-cleared neurostimulation device, the NET Device, to address the addiction crisis, particularly focusing on opioid and stimulant use [1] Company Overview - NET Recovery is associated with Elle Communications, a subsidiary of Dolphin (NASDAQ:DLPN) [1] - The NET Device has shown potential in recent research to significantly reduce both opioid and stimulant use following treatment [1] Industry Context - The announcement comes amid record-high overdose deaths and a lack of FDA-approved medications specifically for stimulant addiction [1] - A peer-reviewed study published in Frontiers in Psychiatry supports the efficacy of the NET Device in reducing substance use [1]